These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2024969)

  • 21. Active efflux of norfloxacin by Bacteroides fragilis.
    Miyamae S; Nikaido H; Tanaka Y; Yoshimura F
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2119-21. PubMed ID: 9687419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
    J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.
    Low DE; Muller M; Duncan CL; Willey BM; de Azavedo JC; McGeer A; Kreiswirth BN; Pong-Porter S; Bast DJ
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1119-21. PubMed ID: 11897603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
    Martínez-Martínez L; García I; Ballesta S; Benedí VJ; Hernández-Allés S; Pascual A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1850-2. PubMed ID: 9661034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
    Prenna M; Montanari MP; Mingoia M; Biavasco F; Ripa S; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):816-9. PubMed ID: 9923533
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.
    Schmitz FJ; Fluit AC; Brisse S; Verhoef J; Köhrer K; Milatovic D
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):281-7. PubMed ID: 10575140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada.
    Harnett N; Brown S; Krishnan C
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1911-3. PubMed ID: 1952866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
    Shalit I; Berger SA; Gorea A; Frimerman H
    Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of the Staphylococcus aureus norA gene, which confers resistance to hydrophilic quinolones].
    Yoshida H
    Nihon Rinsho; 1992 May; 50(5):1042-8. PubMed ID: 1324331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.
    Kim MJ; Yun HJ; Kang JW; Kim S; Kwak JH; Choi EC
    J Antimicrob Chemother; 2003 Apr; 51(4):1011-6. PubMed ID: 12654771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection.
    Witte W; Grimm H
    Epidemiol Infect; 1992 Dec; 109(3):413-21. PubMed ID: 1468526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of sparfloxacin-resistant mutants of Staphylococcus aureus obtained in vitro.
    Ruiz J; Sierra JM; De Anta MT; Vila J
    Int J Antimicrob Agents; 2001 Aug; 18(2):107-12. PubMed ID: 11516932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
    Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C; Voss A; Milatovic D; Braveny I
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
    Davidson RJ; Drobot GR; Karlowsky JA; Zhanel GG; Philips R; Hoban DJ
    J Antimicrob Chemother; 1994 Sep; 34(3):363-70. PubMed ID: 7829410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.